DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Key facts
- Where
- Chapel Hill, United StatesSee the site
Where in United States
- Lineberger Comphrehensive Cancer Center at University of North CarolinaChapel Hill, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- UNC Lineberger Comprehensive Cancer Center
- Trial code
- NCT06296368
- Record updated
- 14 August 2026
- Original description
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.Read full original descriptionShow less
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
Inclusion: Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information; Subjects are willing and able to comply with study procedures based on the judgment of the investigator; Age ≥ 60 years at the time of consent; New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.
Exclusion: Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention; All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:.